Quinn Opportunity Partners LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$597,447
-5.7%
398,2980.0%0.08%
-10.5%
Q2 2023$633,294
+121.6%
398,2980.0%0.09%
+196.6%
Q1 2023$285,739
+23.8%
398,2980.0%0.03%
+3.6%
Q4 2022$230,814
-41.9%
398,298
-4.8%
0.03%
-37.8%
Q3 2022$397,383
-34.2%
418,298
-16.8%
0.04%
-15.1%
Q2 2022$604,000
-8.3%
503,0040.0%0.05%
+89.3%
Q1 2022$659,000
-25.5%
503,0040.0%0.03%
-48.1%
Q4 2021$885,000
+64.5%
503,004
+102.8%
0.05%
+58.8%
Q3 2021$538,000
-38.0%
248,0040.0%0.03%
-37.0%
Q2 2021$868,000248,0040.05%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders